https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-01-23 / Pharmaceutics 2020 Jan;12(2)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-01-23 / Pharmaceutics 2020 Jan;12(2)2020-01-23 00:00:002020-01-23 00:00:00Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells-An Update
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-01-16 / NPJ Vaccines 2020;5:5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-01-16 / NPJ Vaccines 2020;5:52020-01-16 00:00:002020-08-26 13:53:37Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-01-03 / 2020 01;10(1)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-01-03 / 2020 01;10(1)2020-01-03 00:00:002020-01-03 00:00:00Combination Therapy with Vitamin C Could Eradicate Cancer Stem Cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-01-01 / Technol Cancer Res Treat 2020 Jan-Dec;19:1533033820963599
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-01-01 / Technol Cancer Res Treat 2020 Jan-Dec;19:15330338209635992020-01-01 00:00:002020-01-01 00:00:00Efficacy of Combination Neoadjuvant Chemotherapy and Regional Inductive Moderate Hyperthermia in the Treatment of Patients With Locally Advanced Breast Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-01-01 / Cytotherapy 2020 01;22(1):6-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-01-01 / Cytotherapy 2020 01;22(1):6-152020-01-01 00:00:002020-08-26 13:55:22Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-01-01 / Int J Hyperthermia 2020;37(1):711-741
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-01-01 / Int J Hyperthermia 2020;37(1):711-7412020-01-01 00:00:002020-01-01 00:00:00Heating technology for malignant tumors: a review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-01-01 / Integr Cancer Ther 2020 Jan-Dec;19:1534735420932648
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-01-01 / Integr Cancer Ther 2020 Jan-Dec;19:15347354209326482020-01-01 00:00:002020-01-01 00:00:00A Narrative Review of Regional Hyperthermia: Updates From 2010 to 2019
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-12-10 / Br. J. Cancer 2020 Jan;122(1):111-120
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-12-10 / Br. J. Cancer 2020 Jan;122(1):111-1202019-12-10 00:00:002019-12-10 00:00:00Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-12-05 / Cancer Immunol. Immunother. 2020 Jan;69(1):135-145
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-12-05 / Cancer Immunol. Immunother. 2020 Jan;69(1):135-1452019-12-05 00:00:002019-12-05 00:00:00Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-11-27 / Nat Commun 2019 11;10(1):5408
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-11-27 / Nat Commun 2019 11;10(1):54082019-11-27 00:00:002020-08-26 13:58:03Engineering dendritic cell vaccines to improve cancer immunotherapy
